Clinical Development and Regulatory Approval Risks: Innovent's success heavily depends on its ability to successfully complete clinical trials and obtain regulatory approvals for its pipeline products, which is a lengthy, complex, and uncertain process.

Intense Market Competition and Pricing Pressures: The biopharmaceutical market is highly competitive, and Innovent faces competition from established players and new entrants, alongside significant pricing pressures from government procurement policies, particularly in China.

Intellectual Property Protection and Infringement Concerns: Protecting its intellectual property, including patents and trade secrets, is crucial for Innovent, and there is a risk of third-party infringement or challenges to its IP rights, especially given the complexities of IP enforcement in various jurisdictions.